Amitraz

359 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

359

Total Reports

Deaths Reported

360.0%

Death Rate

Active Ingredients

Amitraz

Administration Routes

TopicalUnknownCutaneousOralOtherOphthalmicRespiratory (Inhalation)Subcutaneous

Species Affected

Dog 292

Unknown 49

Human 18

Most Affected Breeds

Unknown 67

Retriever - Labrador 24

Crossbred Canine/dog 23

Boxer (German Boxer) 22

Dog (unknown) 16

Chihuahua 15

Terrier - Bull - American Pit 13

Shih Tzu 10

Bulldog 9

Shepherd Dog - German 9

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 52

Vomiting 43

Depression 42

Emesis 35

Lack of efficacy (ectoparasite) - Demodex 33

Pruritus 28

Ataxia 26

Anorexia 24

Diarrhoea 22

Vials, Leaking 20

Uncoded sign 18

Behavioural disorder NOS 15

Outcome Breakdown

Recovered/Normal

92 (42.4%)

Ongoing

68 (31.3%)

Outcome Unknown

35 (16.1%)

Died

10 (4.6%)

Recovered with Sequela

9 (4.1%)

Euthanized

3 (1.4%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.